[Immunological aspects of premature termination of pregnancies]

Elzbieta Ronin-Walknowska1, Olimpia Sipak-Szmigiel

  • 1Klinika Medycyny Matczyno-Płodowej, Katedry Połoznictwa i Ginekologii PAM.

Medycyna Wieku Rozwojowego
|November 13, 2004
PubMed

In the presented article we report hypotheses, opinions and confirmed results of investigations concerning immunological mechanisms, that play a role in the physiological pregnancy maintenance, natural reproduction failure and artificial reproductive techniques (ART) as well as abilities to diagnose immunological disorders. We pointed the important role of histocompatibility antigens such are class I and class II major histocompatibility antigens with their soluble forms (HLA-I; HLA-II), DQ-alpha and DQ-beta alleles as well as non classic antigens: HLA-G, HLA-C, HLA-E, in modulation of cellular and humoral response, which represent potential alloimmunological mechanism for pregnancy losses. The accurate report of immunological mechanism for recurrent spontaneous abortions caused by maternal production of phospholipid antibodies in antiphospholipid syndrome (APS) or other antibodies implicated as etiological factors in reproductive autoimmune failure syndrome (RAFS) has been demonstrated. We present the utility of identification of, so-called, reproductive immunophenotype, where an increase of some serum lymphocyte subpopulations anticipating pregnancy loss is frequently observed. In the study we describe recommendations and diagnostic capabilities for detection of immunological disturbances in patients undergoing evaluation for repeated pregnancy loss, which could be helpful in choosing the form of therapy.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...